(16:34 GMT) Cytokinetics Price Target Raised to $115.00/Share From $69.00 by UBS
Dow Jones Newswires
Cytokinetics Raised to Buy From Neutral by UBS
- Sources
- Dow Jones Newswires
- Markets
- Stocks
- Active symbols
- NASDAQ:CYTK
- Language
- English
(16:34 GMT) Cytokinetics Price Target Raised to $115.00/Share From $69.00 by UBS